YOLFTbeta
Indofarma Tbk

Indofarma Tbk

INAF · JK · Healthcare / Drug Manufacturers - Specialty & Generic

126.00IDR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close126.00
Open126.00
Day Range126.00 – 126.00
52-Week Range126.00 – 126.00
Volume0
Market Cap390.51B
P/E (TTM)0.00
Forward P/E6.17
EPS-226.69
Dividend Yield0.00%
Beta0.26
50-Day Avg126.00
200-Day Avg126.00

About

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company operates through medicine, Medical devices and Others, and Engineering Pharmaceuticals. It engages in marketing, trading and distribution of medicine and medical devices; and clinical lab. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Sahat Sihombing
  • Employees42
  • HeadquartersJl. Indofarma No. 1, Bekasi, Indonesia, 17530, Indonesia
  • Websitehttps://indofarma.id

Leadership

  • Mr. Sahat SihombingPresident Director · b. 1966
  • Dr. Andi Prazos Apt, M.M.Director of Operations & Director · b. 1969
  • Mr. Warjoko SumediHead of Internal Audit Unit · b. 1971
  • Ms. Hilda YaniCompany Secretary · b. 1976
  • Ms. Weny MaulatsihSecretary of Board of Commissioners · b. 1985

Financials

Income Statement

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue493.37B615.43B687.98B498.21B689.52B684.04B1.03T1.27T1.48T1.13T1.05T1.20T1.16T1.34T1.38T1.62T1.67T1.63T1.59T1.36T1.72T2.90T1.14T523.60B210.38B151.55B
Growth (%)-+24.74%+11.79%-27.58%+38.40%-0.80%+50.09%+24.01%+16.13%-23.91%-6.86%+14.84%-3.94%+15.70%+3.29%+17.41%+3.26%-2.59%-2.35%-14.68%+26.22%+69.15%-60.57%-54.24%-59.82%-27.96%
Cost of Revenue214.02B304.71B555.92B351.58B463.90B484.77B770.72B983.21B1.15T820.42B729.45B807.28B788.15B999.93B1.07T1.29T1.34T1.35T1.31T1.11T1.31T2.45T1.25T695.56B247.89B171.08B
Gross Profit-----199.27B255.96B289.95B333.40B304.64B318.46B396.18B367.90B337.57B312.43B330.05B336.91B282.81B284.22B250.36B400.60B451.65B-110.11B-171.96B-37.51B-19.53B
Gross Margin-----29.13%24.93%22.77%22.55%27.08%30.39%32.92%31.82%25.24%22.62%20.35%20.12%17.34%17.84%18.42%23.35%15.56%-9.62%-32.84%-17.83%-12.89%
Operating Expense-----164.19B193.72B245.24B270.38B258.73B262.02B304.23B289.45B354.00B271.75B271.73B299.68B280.35B258.31B233.42B312.94B399.67B369.44B431.50B216.22B188.69B
Operating Income183.07B172.33B--48.82B35.08B62.23B44.71B63.02B45.91B56.45B91.96B78.44B-16.43B40.68B58.33B37.23B2.46B25.91B16.94B87.66B51.98B-479.54B-603.46B-253.73B-208.22B
Operating Margin37.11%28.00%--7.08%5.13%6.06%3.51%4.26%4.08%5.39%7.64%6.79%-1.23%2.94%3.60%2.22%0.15%1.63%1.25%5.11%1.79%-41.91%-115.25%-120.60%-137.39%
EBITDA-----31.62B56.50B38.19B40.14B45.91B56.45B87.24B85.84B-20.62B49.05B62.54B55.38B30.51B55.87B70.76B86.76B86.68B-479.11B-581.38B-246.54B-195.04B
EBITDA Margin-----4.62%5.50%3.00%2.71%4.08%5.39%7.25%7.43%-1.54%3.55%3.86%3.31%1.87%3.51%5.21%5.06%2.99%-41.88%-111.04%-117.19%-128.70%
Net Income110.29B122.54B--7.24B9.59B15.24B11.08B5.03B2.13B12.55B36.92B42.38B-54.22B1.17B6.57B-17.37B-46.28B-32.74B7.96B27.58M-37.57B-428.49B-720.99B-334.49B-77.99B
Net Income Margin22.35%19.91%--1.05%1.40%1.48%0.87%0.34%0.19%1.20%3.07%3.67%-4.05%0.08%0.40%-1.04%-2.84%-2.06%0.59%0.00%-1.29%-37.45%-137.70%-158.99%-51.46%
R&D-------2.34B1.20B804.08M1.15B1.97B1.08B1.59B1.03B3.64B3.19B2.42B326.87M306.17M501.24M763.95M552.77M592.43M313.35M792.67M
R&D as % of Total Revenue-------0.18%0.08%0.07%0.11%0.16%0.09%0.12%0.07%0.22%0.19%0.15%0.02%0.02%0.03%0.03%0.05%0.11%0.15%0.52%
Interest Expense0000015.58B16.44B16.12B30.27B35.34B22.35B18.15B17.32B30.86B39.00B40.78B52.43B51.33B48.17B36.76B38.25B42.96B38.08B60.49B30.01B30.44B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%2.28%1.60%1.27%2.05%3.14%2.13%1.51%1.50%2.31%2.82%2.51%3.13%3.15%3.02%2.70%2.23%1.48%3.33%11.55%14.27%20.08%

Balance Sheet

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets538.17B811.62B810.03B635.96B523.92B518.82B686.94B1.01T965.81B728.03B733.96B1.11T1.19T1.29T1.25T1.53T1.38T1.53T1.44T1.38T1.71T2.01T1.53T759.83B618.16B535.99B
Total Liabilities245.61B294.19B412.04B368.02B268.26B253.58B406.45B717.87B669.22B429.31B422.69B505.71B538.52B703.72B656.38B941.00B805.88B1.00T945.70B879.00B1.28T1.50T1.45T1.56T1.76T1.24T
Total Equity292.57B510.84B390.44B260.87B255.66B265.25B280.49B291.56B296.59B298.72B311.27B609.19B650.10B590.79B591.96B592.71B575.75B526.41B496.65B504.93B430.32B508.30B86.36B-804.13B-1.14T-706.94B
Cash51.57B73.39B23.14B29.62B29.79B24.83B90.87B361.27B263.29B110.88B120.92B133.42B194.90B121.43B135.75B313.47B56.23B182.59B129.32B151.39B158.18B380.81B269.75B17.07B10.11B5.69B
Total Debt-----21.48B-179.85B277.73B103.29B94.74B81.24B195.47B318.64B239.48B300.88B421.47B500.21B558.34B483.32B457.49B604.84B627.21B701.76B738.98B700.28B
Net Debt------3.36B-90.87B-181.42B14.44B-7.59B-26.18B-52.18B566.28M197.21B103.73B-12.59B365.24B317.62B429.02B331.93B299.31B224.02B357.46B684.68B728.86B694.60B

Cash Flow

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow27.05B--40.70B159.25B-54.87B73.15B83.42B-187.31B40.56B23.71B29.40B-40.91B-141.62B148.73B134.28B-317.96B147.18B-70.39B20.79B46.55B92.90B-75.95B-190.10B-21.65B-209.89B
Investing Cash Flow----8.58B-8.26B-183.97M7.40B-10.15B-18.90B-4.52B-3.45B-6.49B-35.84B-54.39B-19.72B-58.93B-93.50B-46.40B76.48B-9.04B-114.41B-13.40B-4.68B-319.81M-
Financing Cash Flow-125.58B6.86B--30.06B-6.50B179.85B97.89B-175.62B-9.24B-15.28B115.10B118.96B-79.75B62.17B120.16B72.97B63.81B-75.03B-30.68B244.15B13.33B-57.85B14.98B206.32B
Capital Expenditure51.43B21.82B30.59B8.36B642.02M9.20B1.68B2.77B15.41B21.65B5.57B4.60B7.07B36.61B56.05B22.95B59.63B94.87B46.77B2.60B13.78B21.40B13.48B4.74B425.75M0
Free Cash Flow------64.07B71.47B80.65B-202.72B18.91B18.14B24.79B-47.98B-178.23B92.68B111.33B-377.60B52.31B-117.16B18.19B32.77B71.50B-89.42B-194.84B-22.08B-209.89B
Dividends Paid62.80B37.50B60.05B----------4.24B------------
FCF to OCF-----116.77%97.70%96.68%108.23%46.63%76.51%84.34%117.27%125.85%62.31%82.91%118.76%35.54%166.44%87.51%70.40%76.96%117.74%102.49%101.97%100.00%
Dividend Paid to FCF--------------2.38%------------

Earnings

Report DateDec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Aug 16, 2022Nov 23, 2022Dec 31, 2022May 2, 2023Aug 3, 2023
EPS Estimate-------------------------------------------------------
EPS Actual7.89-6.55-6.803.0814.32-6.45-1.0914.226.720.051.944.487.21-3.540.54-16.742.24-12.39-4.044.9111.89-6.44-1.25-2.6412.44-6.32-2.67-0.824.21-11.24-6.04-3.425.76-2.742.82-11.410.76-7.03-0.83-3.3813.81-6.915.41-4.596.100.59-0.270.60-13.04-16.51-12.76-29.81-79.16-19.94-18.89
Surprise-------------------------------------------------------
Timing--------------------------------------------------Pre-marketAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap390.51B
Enterprise Value1.12T
Trailing P/E0.00
Forward P/E6.17
Price / Sales2.39
Price / Book6.53
EPS-226.69
Book Value-238.79
Revenue (TTM)163.57B
Gross Profit (TTM)-911.34M
EBITDA-147.04B
Profit Margin-41.31%
Operating Margin-11.87%
Return on Equity-397.64%
Return on Assets-19.36%
Shares Outstanding3.10B
Shares Float599.27M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20131×
1.37May 3, 2013
20021×
19.77Nov 19, 2002
20011×
12.46Nov 30, 2001